New dialysis filter may improve survival – but study is only observational
NCT ID NCT07561424
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether a new type of dialysis filter (medium cut-off dialyzer) helps kidney patients live longer and have fewer complications compared to standard filters. Researchers will review medical records from 1,000 adults on maintenance dialysis. The study is observational, meaning it watches what happens in real-world care rather than assigning treatments, so it can suggest but not prove benefits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
medium cut-off (MCO) dialyzer (Theranova)
What this could lead to
If MCO dialyzers show better survival or fewer complications, this could point toward a new standard for dialysis care.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by other factors. It cannot prove cause and effect.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIALYSIS PATIENTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AURA
RECRUITINGParis, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••